ro.kimani
Submits third-party assay reports on material purchased directly. Based in Poznań.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.68%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042716 | GHK-Cu | ERP | ERP-2601-F9816 | PeptideMeter | 2026-Q2 | 98.80 | 4.37 | 92.0 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041538 | Tirzepatide | QSC | QSC-2511-N6404 | Janoshik | 2026-Q1 | 98.99 | 2.87 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041279 | Liraglutide | WWB | WWB-2509-J2476 | PeptideMeter | 2025-Q4 | 99.37 | 3.05 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018678 | Ipamorelin | QSC | QSC-2505-G6632 | Medutest | 2025-Q4 | 99.60 | 3.85 | 100.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020592 | Retatrutide | SSA | SSA-2507-W7449 | Janoshik | 2025-Q3 | 98.61 | 3.70 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018630 | Tirzepatide | QSC | QSC-2502-P5432 | Janoshik | 2025-Q3 | 98.31 | 2.25 | 92.2 | Buyer-sourced | 0 | PASS |
| AX-2025-020217 | Semaglutide | GGPeps | GGPE-2501-W1875 | Medutest | 2025-Q1 | 98.09 | 5.69 | 89.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020538 | Semax | SSA | SSA-2410-G6492 | PeptideMeter | 2024-Q4 | 98.68 | 10.13 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2024-005254 | BPC-157 | BCH | BCH-2406-Y4179 | Janoshik | 2024-Q3 | 98.48 | 6.18 | 90.1 | Buyer-sourced | 0 | PASS |